| Ytd | 24.03% | |
| 1y | -0.01% |
| Open | 78.20 | Prev Close | 77.41 | Low | 77.81 | High | 78.54 | Mkt Cap | 4.01B |
| Vol | 24.08K | Avg Vol | 317.13K | EPS | 3.02 | P/E | 25.82 | Forward P/E | 19.62 |
| Beta | 1.23 | Short Ratio | 5.11 | Inst. Own | 55.34% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | 05-11 | Earning | 07-16 | 50-d Avg | 72.47 | 200-d Avg | 67.09 | 1yr Est | 70.33 |
CNS News
NEW YORK, June 29, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers I
NEW YORK, June 29, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers T
NEW YORK, June 29, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers C
NEW YORK, June 29, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers R
NEW YORK, June 29, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Q
HOUSTON, June 25, 2026 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly-owned subsidiary of Plu
Cohen & Steers, Inc. offers institutional-quality closed-end funds focused on real assets and altern
SAN FRANCISCO and BOSTON, June 24, 2026 (GLOBE NEWSWIRE) -- MapLight Therapeutics, Inc. (Nasdaq: MPL
CUPERTINO, Calif., June 23, 2026 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:
Management to update on 2026 mid-year progress, milestones and provide details on its integrated CNS
Partnership delivers real-time DDoS protection and cyber resilience solutions to enterprises, servic
NEW YORK, June 22, 2026 /PRNewswire/ -- The Board of Directors of the Cohen & Steers Closed-End Fund
CAMBRIDGE, Mass., June 22, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico", 3696.HK), a clinical-
NEW YORK, June 18, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceu
PHILADELPHIA & BOSTON--(BUSINESS WIRE)--Latus Bio, Inc. (Latus), a biotechnology company engineering
NEW YORK, June 15, 2026 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) today announced it has comp
CORAL GABLES, Fla., June 11, 2026 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Rel
NEW YORK, June 8, 2026 /PRNewswire/ -- The Board of Directors of the Cohen & Steers Quality Income R
NEW YORK, June 8, 2026 /PRNewswire/ -- Cohen & Steers Quality Income Realty Fund, Inc. (NYSE: RQI) (
NEW YORK, June 8, 2026 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) today reported preliminary a
Cohen & Steers, Inc. (NYSE: CNS) today announced that Amit Muni has been appointed as Executive
Cohen & Steers (NYSE:CNS) reported quarterly earnings of $0.79 per share which missed the analys
Evercore ISI Group analyst John Dunn maintains Cohen & Steers (NYSE:CNS) with a Outperform an
Cohen & Steers, Inc. (NYSE: CNS) today reported preliminary assets under management of $93.1 bil
Cohen & Steers (NYSE:CNS) reported quarterly earnings of $0.81 per share which met the analyst c
Evercore ISI Group analyst John Dunn maintains Cohen & Steers (NYSE:CNS) with a Outperform an
Evercore ISI Group analyst John Dunn maintains Cohen & Steers (NYSE:CNS) with a Outperform an
B of A Securities analyst Craig Siegenthaler maintains Cohen & Steers (NYSE:CNS) with a Under
Cohen & Steers (NYSE: CNS) announced today that funds managed by the Private Real Estate Group o
Evercore ISI Group analyst John Dunn maintains Cohen & Steers (NYSE:CNS) with a Outperform an
B of A Securities analyst Craig Siegenthaler maintains Cohen & Steers (NYSE:CNS) with a Under
Cohen & Steers (NYSE:CNS) reported quarterly earnings of $0.73 per share which missed the analys
B of A Securities analyst Craig Siegenthaler initiates coverage on Cohen & Steers (NYSE:CNS)
Cohen & Steers (NYSE:CNS) reported quarterly earnings of $0.78 per share which beat the analyst
Evercore ISI Group analyst John Dunn maintains Cohen & Steers (NYSE:CNS) with a Outperform an
Cohen & Steers (NYSE:CNS) reported quarterly earnings of $0.78 per share which met the analyst c